title: pp60c-src enhances the acetylcholine receptor-dependent catecholamine release in vaccinia virus-infected bovine adrenal chromaffin cells.
abstract: Secretion of catecholamines by adrenal chromaffin cells is a highly regulated process that involves serine/threonine and tyrosine phosphorylations. The nonreceptor tyrosine kinase pp60c-src is expressed at high levels and localized to plasma membranes and secretory vesicle membranes in these cells, suggesting an interaction of this enzyme with components of the secretory process. To test the hypothesis that pp60c-src is involved in exocytosis, we transiently expressed exogenous c-src cDNA using a vaccinia virus vector in primary cultures of bovine adrenomedullary chromaffin cells. Chromaffin cells infected with a c-src recombinant virus restored the diminished secretory activity accompanying infection by wild type virus alone or a control recombinant virus. The level of enhanced catecholamine release correlated directly with the time and level of exogenous c-src expression. These results could not be attributed to differences in cytopathic effects of wild type versus recombinant viruses as assessed by cell viability assays, nor to differences in norepinephrine uptake or basal release, suggesting that pp60c-src is involved in stimulus-secretion coupling in infected cells. Surprisingly, exogenous expression of an enzymatically inactive mutant c-src also restored catecholamine release, indicating that regions of the introduced c-src protein other than the kinase domain may affect catecholamine release. Secretory activity was elevated by both forms of c-src in response to either nicotine or carbachol (which activate the nicotinic and the nicotinic/muscarinic receptors, respectively). In contrast, release of catecholamines upon membrane depolarization (as elicited by 55 mM K+) or by treatment with the calcium ionophore A23187 was unaffected by either vaccinia infection or increased levels of pp60c-src. These results suggest that pp60c-src affects secretory processes in vaccinia-infected cells that are activated through ligand-gated, but not voltage-gated, ion channels.
authors.affiliation: Department of Microbiology, University of Virginia Health Sciences Center, Charlottesville 22908.
authors.forename: C M
authors.initials: CM
authors.lastname: Ely
authors.forename: W M
authors.initials: WM
authors.lastname: Tomiak
authors.forename: C M
authors.initials: CM
authors.lastname: Allen
authors.forename: L
authors.initials: L
authors.lastname: Thomas
authors.forename: G
authors.initials: G
authors.lastname: Thomas
authors.forename: S J
authors.initials: SJ
authors.lastname: Parsons
mesh_terms: D000311:Adrenal Glands / Q000378:metabolism* / Q000473:pathology; D000818:Animals; D000001:Calcimycin / Q000494:pharmacology; D002217:Carbachol / Q000494:pharmacology; D002395:Catecholamines / Q000378:metabolism*; D002417:Cattle; D002478:Cells, Cultured; D002838:Chromaffin System / Q000378:metabolism* / Q000473:pathology; D015870:Gene Expression; D016391:Genes, src; D009154:Mutation; D009538:Nicotine / Q000378:metabolism; D011188:Potassium / Q000494:pharmacology; D011505:Protein-Tyrosine Kinases / Q000378:metabolism; D016392:Proto-Oncogene Proteins pp60(c-src) / Q000378:metabolism / Q000494:pharmacology*; D011950:Receptors, Cholinergic / Q000502:physiology*; D011995:Recombination, Genetic; D013997:Time Factors; D014615:Vaccinia / Q000378:metabolism* / Q000473:pathology; D014616:Vaccinia virus / Q000235:genetics / Q000472:pathogenicity
chemical_list: D002395:Catecholamines; D011950:Receptors, Cholinergic; D000001:Calcimycin; D009538:Nicotine; D002217:Carbachol; D011505:Protein-Tyrosine Kinases; D016392:Proto-Oncogene Proteins pp60(c-src); D011188:Potassium